Get the Stockscreener App
349.26
0.38%
1.4555
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Amgen Inc stock is traded at $349.26, with a volume of 308.84K.
It is up +0.38% in the last 24 hours and down -7.98% over the past month.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
See More
Previous Close:
$347.80
Open:
$351.8
24h Volume:
308.84K
Relative Volume:
0.11
Market Cap:
$188.26B
Revenue:
$36.74B
Net Income/Loss:
$7.71B
P/E Ratio:
24.54
EPS:
14.2333
Net Cash Flow:
$8.10B
1W Performance:
-4.67%
1M Performance:
-7.98%
6M Performance:
+21.73%
1Y Performance:
+10.47%
1-Day Range:
$348.61
$352.15
1-Week Range:
$344.95
$368.78
52-Week Range:
$261.43
$391.29
Amgen Inc Stock (AMGN) Company Profile
Name
Amgen Inc
Sector
Industry
Phone
(805)447-1000
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, AZN, MRK
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
349.24 | 187.49B | 36.74B | 7.71B | 8.10B | 14.23 |
LLY
Lilly Eli Co
|
912.80 | 809.68B | 65.18B | 20.64B | 5.96B | 22.59 |
JNJ
Johnson Johnson
|
234.48 | 566.92B | 94.19B | 26.80B | 19.70B | 11.05 |
ABBV
Abbvie Inc
|
204.90 | 362.60B | 61.16B | 4.19B | 17.82B | 2.3614 |
AZN
Astrazeneca Plc
|
184.53 | 284.73B | 58.80B | 10.24B | 8.98B | 3.2788 |
MRK
Merck Co Inc
|
115.48 | 282.30B | 64.93B | 18.26B | 12.36B | 7.2751 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-26 | Initiated | Jefferies | Hold |
| Feb-20-26 | Initiated | Barclays | Equal Weight |
| Jan-20-26 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jan-07-26 | Resumed | UBS | Buy |
| Dec-05-25 | Upgrade | Erste Group | Hold → Buy |
| Nov-24-25 | Resumed | Truist | Hold |
| Nov-13-25 | Initiated | Scotiabank | Sector Outperform |
| Sep-03-25 | Resumed | Raymond James | Mkt Perform |
| May-20-25 | Resumed | Guggenheim | Neutral |
| Apr-22-25 | Resumed | Cantor Fitzgerald | Neutral |
| Dec-10-24 | Resumed | BofA Securities | Underperform |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-14-24 | Initiated | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Outperform |
| Oct-14-24 | Downgrade | Truist | Buy → Hold |
| Sep-27-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-03-24 | Upgrade | Barclays | Underweight → Equal Weight |
| May-03-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Mar-28-24 | Resumed | Raymond James | Mkt Perform |
| Feb-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-21-23 | Upgrade | Daiwa Securities | Neutral → Buy |
| Dec-19-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Hold |
| Nov-02-23 | Upgrade | Truist | Hold → Buy |
| Oct-20-23 | Resumed | JP Morgan | Neutral |
| Oct-17-23 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-11-23 | Resumed | BofA Securities | Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Apr-24-23 | Reiterated | Oppenheimer | Outperform |
| Mar-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-13-23 | Reiterated | Truist | Buy |
| Nov-18-22 | Initiated | Credit Suisse | Underperform |
| Oct-31-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-11-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Feb-09-22 | Reiterated | Barclays | Equal Weight |
| Feb-09-22 | Reiterated | Jefferies | Buy |
| Feb-09-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Feb-09-22 | Reiterated | Oppenheimer | Outperform |
| Feb-09-22 | Reiterated | Wells Fargo | Equal Weight |
| Jan-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-21 | Resumed | Wells Fargo | Equal Weight |
| Dec-06-21 | Initiated | Goldman | Buy |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Sep-23-21 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-29-20 | Initiated | Daiwa Securities | Buy |
| Oct-28-20 | Initiated | UBS | Neutral |
| Oct-26-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Oct-12-20 | Upgrade | Truist | Hold → Buy |
| Oct-09-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Oct-09-20 | Downgrade | Truist | Buy → Hold |
| Oct-08-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-15-20 | Resumed | Guggenheim | Neutral |
| Mar-31-20 | Initiated | Wolfe Research | Peer Perform |
| Mar-30-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-05-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Jan-31-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Jan-21-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-24-19 | Initiated | Raymond James | Mkt Perform |
| Dec-17-19 | Resumed | Morgan Stanley | Overweight |
| Nov-12-19 | Initiated | SunTrust | Buy |
| Nov-05-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-19-19 | Downgrade | Mizuho | Buy → Neutral |
| May-23-19 | Upgrade | Citigroup | Neutral → Buy |
View All
Amgen Inc Stock (AMGN) Latest News
Marshall Financial Group LLC Purchases New Position in Amgen Inc. $AMGN - MarketBeat
180 Wealth Advisors LLC Acquires 6,535 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc stock faces institutional selling pressure amid mixed 13F filings and dividend stability - AD HOC NEWS
Amgen Inc. stock faces pressure amid pipeline setbacks and market rotation in biotech sector - AD HOC NEWS
Wealth Enhancement Advisory Services LLC Trims Stake in Amgen Inc. $AMGN - MarketBeat
Nordea Investment Management AB Sells 273,268 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Sarasin & Partners LLP - MarketBeat
Amgen Inc. (AMGN): Billionaire Ken Fisher doubles bullish position - MSN
Amgen Inc. (AMGN) collaborates on ending anti-OX40 clinical studies - MSN
2 Healthcare Stocks to Buy Before They Get Bought Out - The Motley Fool
AMGN Stock Price, Quote & Chart | AMGEN INC (NASDAQ:AMGN) - ChartMill
Amgen buys cancer drug developer Dark Blue in $840 million deal - MSN
Rocatinlimab Halt Puts Spotlight On Amgen Pipeline Risks And Valuation - simplywall.st
Amgen Inc. (AMGN) is attracting investor attention: Here is what you should know - MSN
A28T12 Latest News and Headlines - TradingView
Amgen Expands Oncology Pipeline With New Phase 1 AMG 436 Study in MSI-H/dMMR Tumors - TipRanks
AMGN Trading Above 50 & 200-Day SMA: How to Play the Stock? - TradingView
Amgen (NASDAQ:AMGN) Given New $390.00 Price Target at Wells Fargo & Company - MarketBeat
Wells Fargo Adjusts Price Target on Amgen to $390 From $375, Maintains Equalweight Rating - marketscreener.com
Swiss Life Asset Management Ltd Buys 6,082 Shares of Amgen Inc. $AMGN - MarketBeat
GAMMA Investing LLC Raises Stock Position in Amgen Inc. $AMGN - MarketBeat
Mainstay Capital Management LLC ADV Sells 4,865 Shares of Amgen Inc. $AMGN - MarketBeat
Stillwater Wealth Management Group Purchases New Shares in Amgen Inc. $AMGN - MarketBeat
Investment Research Partners LLC Invests $1.06 Million in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. stock faces pressure amid 2026 guidance scrutiny and sector headwinds - AD HOC NEWS
93,962 Shares in Amgen Inc. $AMGN Acquired by CIBC Bancorp USA Inc. - MarketBeat
Amgen Inc. $AMGN Shares Purchased by AIA Group Ltd - MarketBeat
[Form 4] AMGEN INC Insider Trading Activity - Stock Titan
Amgen (AMGN) EVP David Reese uses 6,022 shares for tax withholding - Stock Titan
Amgen (AMGN) SVP Khosla has 707 shares withheld for taxes, holds 8,291 - Stock Titan
Amgen (AMGN) EVP Jonathan Graham reports tax-withholding of 5,353 shares - Stock Titan
Amgen (AMGN) finance VP reports 327-share tax withholding, holds 4,048 shares - Stock Titan
Bank of America Securities Maintains a Sell Rating on Amgen (AMGN) - MSN
Amgen Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
AMGEN INC. (AMGN) - MSN
Wilmington Savings Fund Society FSB Reduces Holdings in Amgen Inc. $AMGN - MarketBeat
Tcfg Wealth Management LLC Has $1.77 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Valuation Check As Recent Share Momentum Cools - simplywall.st
Amgen Inc. $AMGN is Mizuho Markets Cayman LP's 4th Largest Position - MarketBeat
Danske Bank A S Buys Shares of 358,171 Amgen Inc. $AMGN - MarketBeat
Captrust Financial Advisors Boosts Amgen Inc. Stake by 5.9% - National Today
Amgen Inc. $AMGN Shares Sold by Avity Investment Management Inc. - MarketBeat
Captrust Financial Advisors Has $137.07 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report - AOL.com
Amgen Inc. Shs Thailand Depositary Receipts Repr 1 Sh Trade Ideas — SET:AMGN06 - TradingView
Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Amgen Inc. stock outperforms competitors despite losses on the day - MarketWatch
Amgen Inc. (AMGN): Billionaire Ken Fisher Doubles Bullish Position - Insider Monkey
Amgen Helps Bring Youth Soccer Clinic to Greater Los Angeles with Skills, Drills and Fun Amid Run-up to 2026 World Cup - Amgen
Amgen Inc. $AMGN Shares Purchased by Mariner LLC - MarketBeat
6,457 Shares in Amgen Inc. $AMGN Acquired by Marshall Investment Management LLC - MarketBeat
Amgen Inc Stock (AMGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Amgen Inc Stock (AMGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Santos Esteban | EVP, Operations |
Feb 26 '26 |
Option Exercise |
169.19 |
54,792 |
9,270,143 |
107,119 |
| Santos Esteban | EVP, Operations |
Feb 26 '26 |
Sale |
379.12 |
54,792 |
20,772,595 |
76,618 |
0.01%
1.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):